Current knowledge on molecular resistance to RAS-directed inhibitors in PDAC is summarized, organized into five categories: intrinsic resistance, KRAS-dependent mechanisms, KRAS-independent bypass signaling, downstream pathway reactivation, and tumor microenvironment (TME)-mediated resistance.
M. Pagano Mariano, Enrica Sgarilli, Dirk Mijnlieff et al.· Cancer Drug Resistance· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.